发明名称 DIMERIC IAP INHIBITORS
摘要 Molecular mimics of Smac are capable of modulating apoptosis through their interaction with cellular IAPs (inhibitor of apoptosis proteins). The mimetics are based on a monomer or dimer of the N-terminal tetrapeptide of IAP-binding proteins, such as Smac/DIABLO, Hid, Grim and Reaper, which interact with a specific surface groove of IAP. The mimetics include those based on formula (IVa) and (IVb): (see formula IVa) (see formula IVb) Also disclosed are methods of using these peptidomimetics for therapeutic purposes. In various embodiments of the invention the Smac mimetics of the invention are combined with chemotherapeutic agents, including, but not limited to topoisomerase inhibitors, kinase inbhibitors, NSAIDs, taxanes and platinum containing compounds use broader language.
申请公布号 CA2598995(C) 申请公布日期 2014.07.15
申请号 CA20062598995 申请日期 2006.02.27
申请人 TETRALOGIC PHARMACEUTICALS 发明人 CONDON, STEPHEN M.;LAPORTE, MATTHEW G.;DENG, YIJUN;RIPPIN, SUSAN R.
分类号 C07D403/14;A61K31/404;A61K31/4985;A61K31/551;A61P35/00;C07D405/14;C07D409/14;C07D487/14 主分类号 C07D403/14
代理机构 代理人
主权项
地址